Page last updated: 2024-08-25

alantolactone and Cancer of Liver

alantolactone has been researched along with Cancer of Liver in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmad Khan, MK; Khan, M; Li, T; Ma, T; Nawaz, F; Rasul, A; Sun, M; Zheng, Y1
Lei, JC; Liu, YW; Yin, Y; Yu, JQ; Zou, GL1

Other Studies

2 other study(ies) available for alantolactone and Cancer of Liver

ArticleYear
Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction.
    BioMed research international, 2013, Volume: 2013

    Topics: Acetylcysteine; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Glutathione; Hep G2 Cells; Humans; Lactones; Liver Neoplasms; Membrane Potential, Mitochondrial; Reactive Oxygen Species; Sesquiterpenes, Eudesmane; Signal Transduction; STAT3 Transcription Factor; Transcriptional Activation

2013
Alantolactone induces activation of apoptosis in human hepatoma cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2012, Volume: 50, Issue:9

    Topics: Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Hepatocellular; Caspase 8; Cytochromes c; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Lactones; Liver Neoplasms; Poly(ADP-ribose) Polymerases; Sesquiterpenes, Eudesmane

2012